Delivery Order SPE2D021DA002-SPE2D325F9512

Award Date 4/8/25
Potential Completion Date 4/9/25
Potential Value $16K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $4,808.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of TWINRIX VACCINE SYRINGE and has an ultimate completion date of August 2, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,602.92, is for the delivery of TWINRIX VACCINE SYRINGE and has a completion date of June 21, 2024. DMS Pharmaceutical Group Inc. holds a separate, larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,602.92, is for the delivery of TWINRIX vaccine syringes to the DLA. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, to provide a comprehensive range of pharmaceutical items to...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,602.92, is for the delivery of 4,565,118,241 units of the TWINRIX vaccine syringe. The contract has an ultimate completion date of July 12, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the TWINRIX vaccine syringe, with a ceiling value of $4,007.30 and a period of performance through June 20, 2024. The contract is a delivery order issued under a larger indefinite delivery contract (IDC) with the DLA's Medical Supply Chain division, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,636.62, is a firm fixed-price delivery order for the TWINRIX VACCINE SYRINGE medical supply. The contract has an ultimate completion date of April 8, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $6,546.48, is for the delivery of TWINRIX VACCINE SYRINGE, a specialized pharmaceutical product, by March 11, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through...
This is a $8,014.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of TWINRIX vaccine syringes to support the medical supply needs of military healthcare facilities. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,029.20 firm fixed-price delivery order is for the supply of TWINRIX VACCINE SYRINGE, a vaccine product, with a completion date of October 3, 2024. The contract award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
This is a firm fixed-price delivery order (SPE2D021DA002|SPE2D325F0923) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,014.60 contract is for the delivery of 4566244616 units of the TWINRIX VACCINE SYRINGE. The contract has an ultimate completion date of October 29, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing...
  • SPE2D021DA002
    Indefinite Delivery Contract
  • SPE2D021DA002-SPE2D325F9512
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the provision of the TWINRIX VACCINE SYRINGE with a ceiling value of $16,366.20 and a period of performance through April 9, 2025.

DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers. This contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which allows the DLA to issue firm fixed-price delivery orders for a wide array of pharmaceutical items. The contract does not have a set-aside designation.

Generated 7/8/25, 2:18 PM